Search research articles
Contact Us
Filters
Showing results (51-60 of 368) with videos related to
Page
of 37
Sort By:
NPJ Precision Oncology
|
May 13, 2026
First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemia
Xiaojin Wu, Gao Lu, Lei Tian, et al.
Leukemia & Lymphoma
|
August 10, 2024
The clinical implications of <i>BCOR</i> mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study
Deyuan Hu, Kai Shen, YuSha Guo, et al.
Biochimica Et Biophysica Acta
|
July 20, 2010
Autophagy is a therapeutic target in anticancer drug resistance
Suning Chen, Sumaiyah K Rehman, Wei Zhang, et al.
Scientific Reports
|
March 16, 2018
Intranasal Delivery of Copper Oxide Nanoparticles Induces Pulmonary Toxicity and Fibrosis in C57BL/6 mice
Xiaofeng Lai, Hu Zhao, Yong Zhang, et al.
Annals of Hematology
|
July 25, 2018
Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia
Bin Gu, Xiang Zhang, Guanghua Chen, et al.
American Journal of Hematology
|
February 3, 2007
Analysis of JAK2(V617F) mutation in Chinese patients with myeloproliferative disorders
Suning Chen, Hairong Fei, Ri Zhang, et al.
Leukemia & Lymphoma
|
October 31, 2022
ETV6::ACSL6 fusion gene in myeloid malignancies with eosinophilia: a report of two cases with t(5;12) or normal karyotype
Tingting Zhang, Qian Wang, Yi Xu, et al.
Leukemia & Lymphoma
|
July 9, 2019
Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments
Guangying Sheng, Mengxing Xue, Qinrong Wang, et al.
Leukemia & Lymphoma
|
February 28, 2015
Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation
Jinyi Zhou, Qi Qu, Suning Chen, et al.
Cancer Biology & Therapy
|
July 15, 2016
Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS
Ruohan Zhang, Hongyu Qiao, Suning Chen, et al.
Page
of 37
Search research articles
Search
Showing results (51-60 of 368) with videos related to
Sort By:
Page
of 37
NPJ Precision Oncology
|
May 13, 2026
First-in-human study of FLT3 CAR-T cell therapy for relapsed acute myeloid leukemia
Xiaojin Wu, Gao Lu, Lei Tian, et al.
Leukemia & Lymphoma
|
August 10, 2024
The clinical implications of <i>BCOR</i> mutations in a large cohort of acute myeloid leukemia patients: a 5-year single-center retrospective study
Deyuan Hu, Kai Shen, YuSha Guo, et al.
Biochimica Et Biophysica Acta
|
July 20, 2010
Autophagy is a therapeutic target in anticancer drug resistance
Suning Chen, Sumaiyah K Rehman, Wei Zhang, et al.
Scientific Reports
|
March 16, 2018
Intranasal Delivery of Copper Oxide Nanoparticles Induces Pulmonary Toxicity and Fibrosis in C57BL/6 mice
Xiaofeng Lai, Hu Zhao, Yong Zhang, et al.
Annals of Hematology
|
July 25, 2018
Efficacy of haploidentical hematopoietic stem cell transplantation compared to HLA-matched transplantation for primary refractory acute myeloid leukemia
Bin Gu, Xiang Zhang, Guanghua Chen, et al.
American Journal of Hematology
|
February 3, 2007
Analysis of JAK2(V617F) mutation in Chinese patients with myeloproliferative disorders
Suning Chen, Hairong Fei, Ri Zhang, et al.
Leukemia & Lymphoma
|
October 31, 2022
ETV6::ACSL6 fusion gene in myeloid malignancies with eosinophilia: a report of two cases with t(5;12) or normal karyotype
Tingting Zhang, Qian Wang, Yi Xu, et al.
Leukemia & Lymphoma
|
July 9, 2019
Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments
Guangying Sheng, Mengxing Xue, Qinrong Wang, et al.
Leukemia & Lymphoma
|
February 28, 2015
Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation
Jinyi Zhou, Qi Qu, Suning Chen, et al.
Cancer Biology & Therapy
|
July 15, 2016
Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS
Ruohan Zhang, Hongyu Qiao, Suning Chen, et al.
Page
of 37